Principal Investigator
Amer Beitinjaneh
Enrollment Status
Closed
Clinical Trial ID
Institutional Protocol #
20230349
Clinical Trial Summary
A Phase 1 Study To Assess The Safety And Efficacy Of LYL797, ROR1-Targeting Car T Cells, In Adults With Relapsed And/Or Refractory Solid Tumor Malignancies
Phase
Phase I
Funding Agency/Sponsor
Industrial
Disease
Breast Cancer
Contact Information
Phone Number
305-243-2647